8 April 2024 - Australians with high cholesterol, chronic kidney disease and ovarian cancer now have access to cheaper medicines under ...
8 April 2024 - Hormone therapies for women experiencing menopause are too expensive and inaccessible, and doctors aren’t confident managing ...
4 April 2024 - More than one billion people worldwide live with migraine, and the World Health Organization classifies migraine ...
5 April 2024 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2023 PBAC ...
3 April 2024 - Bausch Health Canada today announced the first public drug plan listings for Uceris (budesonide) aerosol foam ...
1 April 2024 - CADTH has developed a comprehensive and accessible tool to support the validation of economic models used in ...
3 April 2024 - The agenda for the July 2024 PBAC meeting is now available. ...
3 April 2024 - NICE has published final evidence-based recommendations on the use of dostarlimab (Jemperli) in combination with platinum-based ...
2 April 2024 - Roche designed its trial for both approval and health technology assessments but the analyses planned for ...
2 April 2024 - Positive HTA recommendation for reimbursement signifies an important milestone towards public funding to treat eligible patients with ...
2 April 2024 - Breast cancer experts have urged PHARMAC to fast-track the drug Keytruda, for Kiwis with an aggressive ...
28 March 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
28 March 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the ...
28 March 2024 - Another slim agenda; one cancer medicine. ...
1 April 2024 - The April 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...